HIND

US$2.15

Price alerts

Get one email when HIND crosses your level. Checked every 15 minutes during market hours.

▼ -0.04 (-1.83%)down today

Open: US$2.16
High: US$2.18
Low: US$2.12
Prev close: US$2.19

USD · data via Finnhub · delayed/cached up to 1–5 min

Technicals

RSI (14-day)

46.7

Neutral

Above 70 can signal overbought; below 30, oversold.

MACD

0.01

Bearish momentum

MACD below its signal line (0.01).

50-day average

2.17

Price below

Short-term trend reference.

200-day average

3.26

Price below

Long-term trend reference.

Daily values · indicators are descriptive, not trading advice

About ReShape Lifesciences, Inc.

Healthcare · Biotechnology

Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop i…

www.vyometx.com

Key metrics

Market cap: $15M
P/B: 2.24
52-week high: 18.60
52-week low: 1.75
Return on equity: -302.1%
Net margin: -985.5%
Beta: 1.56
1-year return: -80.7%
YTD return: -36.3%

Analyst recommendations

2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-07-01)
2 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-06-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-05-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-04-01)

Similar stocks

Companies in the same industry, via Finnhub

AI research for HIND

Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.

Analyze HIND with AI →